68Ga-DOTA-TOC/NOC in bronchial carcinoids

Nuclear Medicine Communications

Volumn 30, Issue 10, 2009, Pages 822-

  Kumar, Rakesh ^a   Jindal, Tarun ^a   Kumar, Arvind ^a   Dutta, Roman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DOTANOC GA 68; DOTATATE GA 68; DOTATOC GA 68; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

BRONCHUS CARCINOID; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; GASTROINTESTINAL TUMOR; HUMAN; LETTER; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY;

EID: 70349234104     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832cc285     Document Type: Letter

References (4)

1. 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid. Nucl Med Commun 2009; 30:281-286.
2. 3-Octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007; 48:508-518.
3. Aloj L, Caraco C, Tommaselli A, Tarallo L, Aurilio M, Moglie RD, Lastoria S. Ga-68 DOTATOC PET in neuroendocrine tumors. The experience at the National Cancer Institute, Naples, Italy. J Nucl Med 2007; 48 (Suppl 2):152P.
4. 18F-FDG. Cancer 2008; 112:2447-2455.